COMMUNIQUÉS West-GlobeNewswire

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
21/03/2024
Phase 2 MaGic trial in generalized Myasthenia Gravis (gMG) initiated in Q1’24 with top-line results anticipated in 2H’25 $389 million of pro forma cash, including $216 million of net proceeds from a successful PIPE [...]
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
21/03/2024
-- Data from ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Anticipated Q2 2024 -- WATERTOWN, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the [...]
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
21/03/2024
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital [...]
Abusive Referrals for Psychiatric Assessment Are a Tool of Sham Physician Peer Review, according to Journal of American Physicians and Surgeons
21/03/2024
TUCSON, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Sham peer review is often used by hospitals and medical boards to discredit and remove physicians who stand out from the crowd (e.g., innovators, physician [...]
ONWARD® Medical Publishes Prospectus for Listing of New Shares
21/03/2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]
Rate of national measles cases highlights importance of vaccination
21/03/2024
JEFFERSON CITY, Mo., March 21, 2024 (GLOBE NEWSWIRE) -- As vaccine uptake continues to decrease, measles cases or outbreaks have emerged in several states, including Missouri earlier this year. Nationally, the total [...]
Zealand Pharma major shareholder announcement: Van Herk Investments
21/03/2024
Company announcement – No. 18 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 21 March 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a [...]
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
21/03/2024
Bagsværd, Denmark, 21 March 2024 – Novo Nordisk today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing [...]
NTG Nordic Transport Group A/S - Annual General Meeting 2024
21/03/2024
Company announcement no. 4 - 24 21 March 2024 NTG Nordic Transport Group A/S - Annual General Meeting 2024 Today, at 14:00, NTG Nordic Transport Group A/S (“NTG” or the “Company”), CVR no. 12 54 61 06, held its Annual [...]
Infectious Disease Specialist Calls Campaign against Repurposed Drugs in COVID-19 a ‘Great Hypocrisy’
21/03/2024
TUCSON, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Although “off-label” use of drugs approved for a different indication is routine in medical practice, there was an early, aggressive campaign against such use for COVID- [...]
Resolutions from the Annual General Meeting of Novo Nordisk A/S
21/03/2024
Bagsværd, Denmark, 21 March 2024 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, chair of the Board of Directors communicated: “We are very pleased with the [...]
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
21/03/2024
Historic kidney xenotransplantation procedure conducted at Massachusetts General Hospital Tegoprubart administration has now been used investigationally to prevent rejection in both kidney and heart pig-to-human [...]
Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
21/03/2024
PALO ALTO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Sandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicines
21/03/2024
MEDIA RELEASE EUR 50m investment in Kundl plant extension emphasizes commitment to serve more patients with critical antibiotics, produced entirely in Europe Additional manufacturing area of 3,000m 2 means Kundl can now [...]
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
21/03/2024
Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health [...]
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
21/03/2024
Enrollment in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC), continues to progress well; top-line data from this study [...]
Evn Introduces Innovative CBD+THC Ashwagandha Gummies for Optimal Stress Adaptation and Recovery
21/03/2024
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Evn , a leader in hemp-derived cannabinoid products, is excited to announce the launch of its new product, Ashwagandha Gummies infused with CBD and THC, aimed at aiding [...]
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
21/03/2024
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over [...]
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
21/03/2024
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM ET -- ATLANTA, March [...]

Pages